Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PLRZ
PLRZ
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PLRZ News
uniQure Shares Surge After FDA Softens Stance on Gene Therapy
3d ago
NASDAQ.COM
Polyrizon Receives Notice of U.S. Patent Application for Drug Delivery Technology
3d ago
seekingalpha
Polyrizon Partners with European Medical Center for NASARIX™ Study
5d ago
Newsfilter
Polyrizon Signs Agreements with Three Clinical Sites for NASARIX™ Study
Jun 08 2026
Newsfilter
Biotech Stocks Surge with Akari Leading the Rally
May 26 2026
NASDAQ.COM
Polyrizon Signs Clinical Trial Agreement for NASARIX Allergy Blocker
May 13 2026
Newsfilter
Polyrizon Advances Biophysical Barrier Technology Amid Respiratory Threats
May 11 2026
PRnewswire
Polyrizon Advances Biophysical Barrier Technology for Respiratory Defense
May 11 2026
Newsfilter
Polyrizon Files New Patent to Enhance Drug Delivery
Apr 27 2026
Newsfilter
Polyrizon Closes $3.5 Million Financing Round
Apr 08 2026
Newsfilter
Polyrizon Secures $3.5 Million Financing for Intranasal Therapies
Apr 07 2026
NASDAQ.COM
Polyrizon Provides Business Update for 2025
Mar 26 2026
Newsfilter
Polyrizon Ltd. Reports FY Loss and Acquisition Plans
Mar 26 2026
seekingalpha
Polyrizon Files Annual Report for Fiscal Year 2025
Mar 25 2026
Newsfilter
Polyrizon Signs MOU to Acquire Stake in Colugo Systems
Mar 24 2026
NASDAQ.COM
Polyrizon Signs MOU to Acquire Stake in Colugo Systems
Mar 24 2026
seekingalpha
Show More News
